Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration.

The pharmacokinetics of imipenem-cilastatin were investigated in 12 critically ill patients with acute renal failure (ARF) managed by continuous veno-venous hemofiltration (CVVH) while receiving a fixed combination of 500 mg of imipenem-cilastatin intravenously three or four times daily. No adverse...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Tegeder, I, Bremer, F, Oelkers, R, Schobel, H, Schüttler, J, Brune, K, Geisslinger, G
Формат: Artigo
Язык:Inglês
Опубликовано: 1997
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC164183/
https://ncbi.nlm.nih.gov/pubmed/9420033
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы